Horizon Therapeutics Public Ltd Co

STRS OHIO

Report date

9/30/2023

Quarter

2023 Q3

Filed

10/26/2023

Shares

478,470

Value ($000)

55,354

Weight

0.2%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	10/26/2023	55,354	0.2%	478,470	9/30/2023
2023 Q2	7/31/2023	71,139	0.3%	691,679	6/30/2023
2023 Q1	4/27/2023	78,098	0.4%	715,581	3/31/2023
2022 Q4	1/26/2023	80,058	0.4%	703,500	12/31/2022
2022 Q3	10/27/2022	44,282	0.2%	715,500	9/30/2022
2022 Q2	7/25/2022	56,590	0.3%	709,506	6/30/2022
2022 Q1	4/21/2022	61,307	0.2%	582,719	3/31/2022
2021 Q4	1/24/2022	51,815	0.2%	480,839	12/31/2021
2021 Q3	10/22/2021	40,365	0.2%	368,502	9/30/2021
2021 Q2	7/26/2021	15,227	0.1%	162,616	6/30/2021
2021 Q1	4/23/2021	15,667	0.1%	170,221	3/31/2021
2020 Q4	1/25/2021	11,231	0.0%	153,547	12/31/2020
2020 Q3	12/14/2020	1,078	0.0%	13,882	9/30/2020
2020 Q2	7/23/2020	1,363	0.0%	24,529	6/30/2020
2020 Q1	4/23/2020	596	0.0%	20,133	3/31/2020
2019 Q4	1/24/2020	692	0.0%	19,134	12/31/2019